T&R Biofab Co., Ltd. (KOSDAQ:246710)
South Korea · Delayed Price · Currency is KRW 2,230.00
-45.00 (-1.98%)
Sep 21, 2026, 3:30 PM KST
T&R Biofab Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 6,029 | 7,761 | 16,672 | 20,228 |
Short-Term Investments | 100 | 100 | - | 22,000 |
Trading Asset Securities | - | - | 603.74 | 9,519 |
Cash & Short-Term Investments | 6,129 | 7,861 | 17,276 | 51,747 |
Cash Growth | -35.44% | -54.50% | -66.62% | - |
Accounts Receivable | 6,709 | 4,685 | 2,251 | 1,476 |
Other Receivables | - | 702.58 | 814.85 | 612.79 |
Receivables | 6,709 | 5,387 | 3,066 | 2,088 |
Inventory | 3,958 | 3,707 | 4,717 | 2,478 |
Prepaid Expenses | - | 366.21 | 561.16 | 374 |
Other Current Assets | 1,100 | 1,035 | 674.41 | 871.45 |
Total Current Assets | 17,896 | 18,356 | 26,294 | 57,558 |
Property, Plant & Equipment | 59,459 | 59,925 | 61,330 | 34,836 |
Long-Term Investments | 806.77 | 806.77 | 2,285 | 2,996 |
Other Intangible Assets | 1,024 | 947.47 | 978.48 | 831.24 |
Long-Term Deferred Charges | 123.86 | 199.53 | 350.86 | - |
Other Long-Term Assets | 13,445 | 12,479 | 7,215 | 3,595 |
Total Assets | 92,754 | 92,714 | 98,453 | 99,816 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Accounts Payable | 802.26 | 437.91 | 503 | 13.31 |
Accrued Expenses | - | 505.32 | 584.66 | 362.23 |
Short-Term Debt | 13,510 | 5,470 | 22,468 | 28,299 |
Current Portion of Leases | 615.62 | 815.36 | 752.09 | 1,019 |
Current Unearned Revenue | - | - | - | 149.35 |
Other Current Liabilities | 38,960 | 6,631 | 14,196 | 21,106 |
Total Current Liabilities | 54,043 | 13,860 | 38,503 | 50,949 |
Long-Term Debt | 16,045 | 23,068 | 22,490 | 16,200 |
Long-Term Leases | 203.38 | 208.39 | 345.7 | 503.38 |
Pension & Post-Retirement Benefits | 1,120 | 990.49 | 524.38 | - |
Other Long-Term Liabilities | 139.58 | 28,516 | 10,035 | 966.07 |
Total Liabilities | 71,550 | 66,643 | 71,899 | 68,619 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Common Stock | 23,832 | 23,785 | 10,773 | 10,762 |
Additional Paid-In Capital | 166,800 | 166,411 | 145,367 | 145,327 |
Retained Earnings | -175,315 | -170,027 | -138,331 | -130,518 |
Treasury Stock | -2.12 | -2.12 | - | - |
Comprehensive Income & Other | 5,889 | 5,904 | 6,401 | 5,627 |
Total Common Equity | 21,204 | 26,071 | 24,211 | 31,197 |
Shareholders' Equity | 21,204 | 26,071 | 26,554 | 31,197 |
Total Liabilities & Equity | 92,754 | 92,714 | 98,453 | 99,816 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | 30,529 | 29,562 | 46,056 | 46,021 |
Net Cash (Debt) | -24,401 | -21,702 | -28,780 | 5,725 |
Net Cash Growth | - | - | - | - |
Net Cash Per Share | -541.45 | -678.76 | -1113.17 | 225.01 |
Filing Date Shares Outstanding | 47.66 | 47.56 | 25.86 | 25.83 |
Total Common Shares Outstanding | 47.66 | 47.56 | 25.86 | 25.83 |
Working Capital | -36,147 | 4,496 | -12,209 | 6,609 |
Book Value Per Share | 444.90 | 548.11 | 936.37 | 1207.85 |
Tangible Book Value | 20,180 | 25,123 | 23,233 | 30,366 |
Tangible Book Value Per Share | 423.42 | 528.19 | 898.53 | 1175.67 |
Land | 24,290 | 24,290 | 24,290 | 9,745 |
Buildings | 25,400 | 27,200 | 21,568 | 4,072 |
Machinery | 7,646 | 18,254 | 20,378 | 4,535 |
Construction In Progress | 985.1 | 611.6 | 5,706 | 17,476 |